Cargando…
miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells
As the most common malignant primary bone tumor in childhood, osteosarcoma (OS) maintains a high recurrence, despite the significant improvements in the overall survival rate of high-grade OS patients during the recent decades. Therefore, a novel therapy strategy is required for OS treatment. Recent...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186385/ https://www.ncbi.nlm.nih.gov/pubmed/25289062 http://dx.doi.org/10.3892/etm.2014.1942 |